Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06773962 · ClinicalTrials.gov registry record · Phase 2
A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease
A Phase 2 study of Parkinsons Disease (PD), sponsored by TrueBinding.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 62
- Enrollment target
- 14
- Study locations
NCT06773962: Recruiting Phase 2 study of Parkinsons Disease (PD), sponsored by TrueBinding.
NCT06773962 is a Phase 2 study of Parkinsons Disease (PD) that is actively recruiting participants, run by TrueBinding. The registered enrollment target is 62 participants, below the 116-participant average among 19 other Parkinsons Disease (PD) trials with a reported enrollment target (47% lower). The trial reports 14 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06773962, a Phase 2 study of Parkinsons Disease (PD), is actively recruiting participants, sponsored by TrueBinding.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 62 participants
- Enrollment target
- 14
- Study locations
Study Summary
The primary objectives of this study are to assess the efficacy of TB006 in improving motor function and to assess the safety of TB006 in participants with Parkinson's Disease (PD).
Conditions Studied
Interventions
- DRUG Placebo
- DRUG TB006
Study Locations (14)
Florida
- Parkinson's Disease and Movement Disorders Center of Boca Raton - Boca Raton
- University of Miami - Miami
- University of South Florida Parkinson's and Movement Disorders Center - Tampa
California
- Parkinson's Research Centers of America - Orange County - Aliso Viejo
- Parkinson's Research Centers of America - Palo Alto - Palo Alto
New York
- Parkinson's Research Centers of America - Long Island - Commack
- NYU Langone Health - Patchogue
Colorado
- CenExel Rocky Mountain Clinical Research - Englewood
Illinois
- Consultants in Neurology, Ltd - Northbrook
Indiana
- Josephson Wallack Munshower Neurology - Southeast - Indianapolis
Kansas
- University of Kansas Medical Center - Kansas City
Michigan
- Quest Research Institute - Farmington Hills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2025-03-20 |
| Est. Completion | 2026-09-01 |
| Phase | Phase 2 |
What NCT06773962 shows while recruiting
NCT06773962 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 116-participant average among 19 other Parkinsons Disease (PD) trials with a reported enrollment target (47% lower).
The record links to 1 condition, with Parkinsons Disease (PD) appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06773962 lists 14 locations in 10 states (Florida, California, New York).
Frequently Asked Questions
What is clinical trial NCT06773962 about?
NCT06773962 is a clinical study titled "A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease". The primary objectives of this study are to assess the efficacy of TB006 in improving motor function and to assess the safety of TB006 in participants with Parkinson's Disease (PD).
What is the current status of trial NCT06773962?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 62 participants. The study started on 2025-03-20. Estimated completion is 2026-09-01.
What conditions does trial NCT06773962 study?
This clinical trial studies the following conditions: Parkinsons Disease (PD).
What interventions are being tested in trial NCT06773962?
The interventions under investigation include: Placebo (DRUG), TB006 (DRUG).
Who is sponsoring clinical trial NCT06773962?
This trial is sponsored by TrueBinding, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06773962 being conducted?
This trial has 14 study locations across California, Colorado, Florida, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinsons Disease (PD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06773962's enrollment target sits among peer trials
62 13th of 19 higher than 7 of 19 other Parkinsons Disease (PD) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinsons Disease (PD) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of NE3107 in Early Parkinson's
RECRUITING · Phase 2
-
A Study of Buntanetap in Participants With PD
RECRUITING · Phase 2
-
Transcranial Direct Current Stimulation for Motor Function and Fatigue in PD
RECRUITING · NA
-
Study to Investigate Vagus Nerve Stimulation to Augment Executive Function in Healthy and Cognitively Impaired Populations
RECRUITING · NA
-
Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.
RECRUITING · Phase 1
-
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI